ENZ — Enzo Biochem Cashflow Statement
0.000.00%
Last trade - 00:00
- $53.79m
- -$2.92m
- $31.06m
- 55
- 43
- 34
- 40
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.49 | -28.5 | 7.88 | -18.3 | 20.3 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 2.29 | 0.604 | -5.37 | 5.68 | -78.5 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.01 | 7.96 | -4.77 | -6.83 | 18.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | 4.81 | -17.2 | 0.387 | -16.6 | -37 |
Capital Expenditures | -8.13 | -2.17 | -4.44 | -3.47 | -2.76 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 0 | -30.1 | 28.7 | 102 |
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -8.13 | -2.17 | -34.5 | 25.2 | 99 |
Financing Cash Flow Items | -0.07 | 0 | 0 | — | -0.389 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4.19 | 7 | -0.242 | -0.241 | -1.13 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.855 | -12.3 | -34.3 | 8.33 | 60.8 |